The Alternative Pathway C3/C5 Convertase: Chemical Basis of Factor B Activation
Open Access
- 1 August 1979
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 123 (2) , 529-534
- https://doi.org/10.4049/jimmunol.123.2.529
Abstract
The structural basis of activation of the alternative pathway C3 convertase was explored. For this purpose a modified isolation procedure of the activating enzyme, Factor D, was elaborated. The procedure affords a 70,000-fold purification of the enzyme with a 20% yield. A simple assay was designed for the quantitation of both Factor D and Factor B activity. On the basis of activity measurements and amino acid analysis, Factor D concentration in plasma was estimated to be 1 µg/ml. Highly purified Factor D was used to activate Factor B in the presence of C3b and Mg++. The resulting fragments, Ba and Bb, were characterized with respect to their circular dichroism spectra, amino acid compositions, reactive sulfhydryl groups, and partial amino- and carboxy-terminal sequences. The results indicate that the BA fragment constitutes the amino-terminal region and the Bb fragment the carboxy-terminal region of Factor B. The bond in Factor B that is cleaved by Factor D is proposed to be an arginyl-lysine bond.This publication has 10 references indexed in Scilit:
- Assembly of the cytolytic alternative pathway of complement from 11 isolated plasma proteins.The Journal of Experimental Medicine, 1978
- Mechanism of action of factor D of the alternative complement pathway.The Journal of Experimental Medicine, 1978
- Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.Proceedings of the National Academy of Sciences, 1978
- The purification and properties of the second component of human complementBiochemical Journal, 1978
- Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.The Journal of Experimental Medicine, 1977
- ACTIVATION OF C3B FEEDBACK CYCLE WITH HUMAN COMPLEMENT COMPONENTS .2. USING COMPONENTS OF ALTERNATIVE PATHWAY1977
- HUMAN FACTOR-D OF ALTERNATIVE COMPLEMENT PATHWAY - PURIFICATION AND CHARACTERIZATION1977
- The Serine Protease Nature of the C3 and C5 Convertases of the Classical and Alternative Complement PathwaysScandinavian Journal of Immunology, 1976
- ENHANCEMENT OF THE HEMOLYTIC ACTIVITY OF THE SECOND COMPONENT OF HUMAN COMPLEMENT BY OXIDATIONThe Journal of Experimental Medicine, 1967
- A computer program for the calculation of amino acid analysis dataAnalytical Biochemistry, 1967